摘要:
The invention provides a pharmaceutical product, kit or composition comprising a first active ingredient which is N-Cyclohexyl-N3-[2-(3-fluorophenyl)ethyl]-N-(2-{[2-(4-hydroxy-2-oxo-2,3-dihydro-1,3-benzothiazol-7-yl)ethyl]amino}ethyl)-β-alaninamide or a salt thereof, and a second active ingredient selected from: a non-steroidal Glucocorticoid Receptor (GR Receptor) Agonist; an antioxidant; a CCR1 antagonist; a chemokine antagonist (not CCR1); a corticosteroid; a CRTh2 antagonist; a DP1 antagonist; an Histone Deacetylase Inducer; an IKK2 inhibitor; a COX inhibitor; a lipoxygenase inhibitor; a leukotriene receptor antagonist; an MPO inhibitor; a muscarinic antagonist; a p38 inhibitor; a PDE inhibitor; a PPARγ agonist; a protease inhibitor; a Statin; a thromboxane antagonist; a vasodilator; or, an ENAC blocker (Epithelial Sodium-channel blocker); and its use in the treatment of respiratory disease (for example chronic obstructive pulmonary disease (COPD) or asthma); to certain salts of N-Cyclohexyl-N3-[2-(3-fluorophenyl)ethyl]-N-(2-{[2-(4-hydroxy-2-oxo-2,3-dihydro-1,3-benzothiazol-7-yl)ethyl]amino}ethyl)-β-alaninamide and to an intermediate useful in the manufacture of this pharmaceutically active substance and salts thereof.
摘要:
The present invention provides compounds of formula (I), wherein k, Ar, R2, R3, R4, R5, R4′, R5′, R6, R7, A, D, m and E are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.
摘要:
Sets of tessellatable elements are disclosed, in which a relatively low number of different elements may be combined together to provide very attractive tessellating patterns. The elements may be in the form of tiles, for paving or for covering flooring or walls, for example, game pieces, including television and computer games, pieces for use in maze construction and for many other applications.
摘要:
A method of ensuring high integrity of a processor is provided. The method includes executing sets of sequential instructions, each execution being based on a unique initial value, generating a computed final value responsive to each execution of a set of sequential instructions, and sending computed values to a monitoring portion of a high integrity processor monitor system responsive to the generating for each execution of the set of sequential instructions. The execution of the sets of sequential instructions tests pertinent addressing modes, operand sizes, and instruction side-effects for each instruction tested in a monitored central processing unit.
摘要:
Sets of tessellatable polygonal elements are provided from which a variety of tessellations may be formed for a variety of applications, e.g., to provide coverings and decorations for surfaces such as pedestrian walks, driveways, floors and walls, and to provide patterns for games, puzzles and coloring books. Several different embodiments, applications and tessellations are described. In one embodiment, irregular heptagonal elements are tessellated with substantially regular pentagonal elements. In another embodiment, the elements are heptagonal and square. The tessellations may have straight edges by providing one or more elements of the set of tessellatable elements with a line of symmetry and providing a further tessellatable element or elements which is that part of the element on either side of the line of symmetry. The elements may be colored to provide many variations and decorations. The tessellatable elements described herein may also tessellate with standard size elements of the same or compatible type element.
摘要:
A method of ensuring high integrity of a processor is provided. The method includes executing sets of sequential instructions, each execution being based on a unique initial value, generating a computed final value responsive to each execution of a set of sequential instructions, and sending computed values to a monitoring portion of a high integrity processor monitor system responsive to the generating for each execution of the set of sequential instructions. The execution of the sets of sequential instructions tests pertinent addressing modes, operand sizes, and instruction side-effects for each instruction tested in a monitored central processing unit.
摘要:
The present invention provides compounds of formula (I) wherein k, Ar, R2, R3, R4, R5, R4′, R5′, R6, R7, A, D, m and E are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.